ID   IST-Mes3
AC   CVCL_C312
SY   IST-MES3; Istituto Scientifico Tumori-Mesothelioma 3
DR   Wikidata; Q54898349
RX   PubMed=10232421;
RX   PubMed=16704740;
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 12
//
RX   PubMed=10232421; DOI=10.1183/09031936.99.13352799;
RA   Orengo, Anna Maria
RA   Spoletini, Luciana
RA   Procopio, Antonio
RA   Favoni, Roberto E.
RA   De Cupis, Alessandra
RA   Ardizzoni, Andrea
RA   Castagneto, Bruno
RA   Ribotta, M.
RA   Betta, Pier Giorgio
RA   Ferrini, Silvano
RA   Mutti, Luciano
RT   "Establishment of four new mesothelioma cell lines: characterization
RT   by ultrastructural and immunophenotypic analysis.";
RL   Eur. Respir. J. 13:527-534(1999).
//
RX   PubMed=16704740; DOI=10.1186/1471-2407-6-130; PMCID=PMC1483896;
RA   Martarelli, Daniele
RA   Catalano, Alfonso
RA   Procopio, Antonio
RA   Orecchia, Sara
RA   Libener, Roberta
RA   Santoni, Giorgio
RT   "Characterization of human malignant mesothelioma cell lines
RT   orthotopically implanted in the pleural cavity of immunodeficient mice
RT   for their ability to grow and form metastasis.";
RL   BMC Cancer 6:130.1-130.7(2006).
//